This message contains graphics. If you do not see the graphics, click here to view.
 
 

 

Insider's Report: President Trump Has Broken His Promise to Seniors

seniors_dining

As a candidate, Donald Trump promised voters that he would allow Medicare to negotiate drug prices, which would go a long way to reining in soaring prescription drug costs. In 2016, candidate Trump stated, "when it comes time to negotiate the cost of drugs, we are going to negotiate like crazy." Yet President Trump has refused to date to follow through on that campaign promise; and worse, he has come out against Speaker of the House Nancy Pelosi's sweeping drug bill that includes this important provision.


At a time when high drug costs are forcing many older Americans to ration their medications or simply forgo the lifesaving drugs they need altogether, President Trump has so far rejected common sense drug pricing legislation that has the support of a large number of lawmakers in the House of Representatives. As you know, large drug companies have a lot of power and influence in Washington and they're putting enormous pressure on President Trump and members of Congress to oppose legislation that would cut into their bottom line (Huge Profits!) and help level the playing field.


A recent report found that nearly eight in ten Americans say the cost of prescription drugs is unreasonable, with voters from both parties agreeing that reducing the cost of prescription drugs should be one of Congress' top priorities. For years, the National Committee has been beating the drum about seniors' rising health care costs. That's why the National Committee has launched our nationwide "Don't Cut Pills, Cut Profits" campaign.


The National Committee is committed to raising awareness about this crucial issue among more Americans, the media and our elected officials, and ultimately building enough support in Congress and the Trump Administration for legislation that will curb high drug prices and ensure older Americans have access to affordable, quality prescription drugs.

 
 



Please consider becoming a member now to help us keep the pressure on Congress. Your continued support is essential to the National Committee's mission of protecting your earned benefits.

recent_headline Good Bills 

 

The National Committee endorses the "Medicare Negotiation and Competitive Licensing Act" (H.R. 1046 / S.377), introduced by Representative Lloyd Doggett (TX-35) and Senator Sherrod Brown (OH), which would empower the Secretary of Health & Human Services to directly negotiate prices for prescription drugs and, in the event negotiations fail, would allow Medicare to issue a license to another company to produce the drug at a reasonable cost. (Currently, Medicare is prohibited by law from negotiating with drug companies for lower prices.) This bill would provide drug companies with a strong incentive to negotiate a reasonable price.

 

Nobody should have to choose between paying their bills for the basic costs of living and taking their medication. The National Committee urges Congress to tackle the issue of rising prescription drug costs. Supporting and ultimately passing the "Medicare Negotiation and Competitive Licensing Act" would be an important step toward curbing high drug costs in the Medicare program.

 
social security card Take Our Poll! 

 

Prescription drug prices are out of control — and older Americans are disproportionately feeling the financial pain at the pharmacy counter. Prices for the most commonly prescribed drugs for seniors have increased ten times (!) the rate of inflation since 2013. Medicare beneficiaries pay thousands of dollars a year in out-of-pocket drug costs they can't afford. Some seniors have been cutting pills in half or outright skipping doses of lifesaving medications. Others are forced to choose between medicine and essentials like rent and groceries. Meanwhile, Big Pharma rakes in record profits. That's not acceptable in the wealthiest nation on Earth.

 

Please tell us: Should Congress and the White House make it a top priority in the weeks ahead to reach a deal on lowering prescription drug prices in America?

 

Take our poll now!

 
recent_headline Ask Us

 

Did you know that a team of experts in the field of Social Security policy is available to answer your questions about benefits? For 37 years, the National Committee has been helping thousands of our members and supporters with a broad range of concerns on Social Security.

 

Whether you're currently retired or approaching retirement, the National Committee's "Ask Us" section can help answer your questions about Social Security. You can either search our archives for valuable advice on a broad range of concerns at www.ncpssm.org/ask-us-recent/ or email your question to [email protected].

 

This week's question is: I am eligible for benefits; my husband does not have enough credits. I know he will receive survivor benefits if I die, but does he receive any income if both are alive?

 

Click here to read the answer.

 
recent_headline Recent Headlines


Why Michigan Struggles with Prescription Drug Costs
 (November 25, 2019, WJIM, Radio Interview with NCPSSM Director of Government Relations & Policy, Dan Adcock)

 

The Shocking Rise of Prescription Drug Prices (November 26, 2019, Consumer Reports, Lisa L. Gill)

 

Trump draws ire after retreat on drug prices pledge (November 24, 2019, The Hill, Peter Sullivan)

 

Drugmakers Cut Prices 61% to Get on Coveted China List (November 27, 2019, Bloomberg, drafted with assistance from Dong Lyu, and Jeanny Yu)

 

The $11 Million Dollar Medicare Tool That Gives Seniors the Wrong Insurance Information (November 25, 2019, ProPublica, Akilah Johnson)

 

Many Americans Over 65 Face Economic Insecurity, Even If They're Healthy (November 19, 2019, Bloomberg, Alexandre Tanzi)

 
 


 

Member contributions to the National Committee, a nonprofit 501(c)(4) organization, are not tax-deductible.

Copyright© 2019 by the National Committee
111 K Street, NE, Suite 700 | Washington, DC 20002
www.ncpssm.org | 1-800-966-1935

Privacy Policy | Disclosure Statement | Click here to join
Click here to forward this email | Click here to unsubscribe